123 reports of this reaction
3.3% of all VECURONIUM BROMIDE reports
#2 most reported adverse reaction
HYPOTENSION is the #2 most commonly reported adverse reaction for VECURONIUM BROMIDE, manufactured by Eugia US LLC. There are 123 FDA adverse event reports linking VECURONIUM BROMIDE to HYPOTENSION. This represents approximately 3.3% of all 3,750 adverse event reports for this drug.
Patients taking VECURONIUM BROMIDE who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among VECURONIUM BROMIDE users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for VECURONIUM BROMIDE:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 123 FDA reports for VECURONIUM BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.3% of all adverse event reports for VECURONIUM BROMIDE, making it one of the most commonly reported side effect.
If you experience hypotension while taking VECURONIUM BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.